Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis

Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis

The increasing use of targeted therapy (TT) has resulted in prolonged disease control and survival in many metastatic cancers. In parallel, stereotactic radiotherapy (SRT) is increasingly performed in patients receiving TT to obtain a durable control of resistant metastases, and thereby to prolong t...

Full description

Bibliographic Details
Main Authors: Stephanie G. C. Kroeze, Corinna Fritz, Jana Schaule, Oliver Blanck, Klaus Henning Kahl, David Kaul, Shankar Siva, Sabine Gerum, An Claes, Nora Sundahl, Sonja Adebahr, Susanne Stera, Markus M. Schymalla, Nasrin Abbasi-Senger, Daniel Buergy, Michael Geier, Marcella Szuecs, Fabian Lohaus, Guido Henke, Stephanie E. Combs, Matthias Guckenberger
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
stereotactic
metastasis-directed radiotherapy
targeted therapy
concurrent
tyrosine kinase inhibitors
BRAF inhibitors
Online Access:https://www.mdpi.com/2072-6694/13/19/4780

Internet

https://www.mdpi.com/2072-6694/13/19/4780

Similar Items